Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Cash (2019 - 2025)

Historic Change in Cash for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$9.5 million.

  • Korro Bio's Change in Cash rose 6615.85% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.8 million, marking a year-over-year decrease of 33888.11%. This contributed to the annual value of -$114.1 million for FY2024, which is 18665.17% down from last year.
  • Per Korro Bio's latest filing, its Change in Cash stood at -$9.5 million for Q3 2025, which was up 6615.85% from -$30.5 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Change in Cash registered a high of $121.8 million during Q4 2023, and its lowest value of -$51.1 million during Q1 2021.
  • Over the past 5 years, Korro Bio's median Change in Cash value was -$18.2 million (recorded in 2023), while the average stood at -$10.4 million.
  • In the last 5 years, Korro Bio's Change in Cash crashed by 120295.64% in 2021 and then skyrocketed by 189737.39% in 2023.
  • Quarter analysis of 5 years shows Korro Bio's Change in Cash stood at -$32.4 million in 2021, then skyrocketed by 79.1% to -$6.8 million in 2022, then skyrocketed by 1897.37% to $121.8 million in 2023, then crashed by 107.66% to -$9.3 million in 2024, then fell by 1.34% to -$9.5 million in 2025.
  • Its Change in Cash was -$9.5 million in Q3 2025, compared to -$30.5 million in Q2 2025 and $8.5 million in Q1 2025.